File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.idc.2010.04.001
- Scopus: eid_2-s2.0-77955240755
- PMID: 20674794
- WOS: WOS:000281349500006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Emerging, novel, and known influenza virus infections in humans
Title | Emerging, novel, and known influenza virus infections in humans |
---|---|
Authors | |
Keywords | Epidemiology H1N1 Influenza Pandemic Transmission Treatment |
Issue Date | 2010 |
Publisher | WB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/cind |
Citation | Infectious Disease Clinics Of North America, 2010, v. 24 n. 3, p. 603-617 How to Cite? |
Abstract | Influenza viruses continue to cause yearly epidemics and occasional pandemics in humans. In recent years, the threat of a possible influenza pandemic arising from the avian influenza A(H5N1) virus has prompted the development of comprehensive pandemic preparedness programs in many countries. The recent emergence of the pandemic influenza A(H1N1) 2009 virus from the Americas in early 2009, although surprising in its geographic and zoonotic origins, has tested these preparedness programs and revealed areas in which further work is necessary. Nevertheless, the plethora of epidemiologic, diagnostic, mathematical and phylogenetic modeling, and investigative methodologies developed since the severe acute respiratory syndrome outbreak of 2003 and the subsequent sporadic human cases of avian influenza have been applied effectively and rapidly to the emergence of this novel pandemic virus. This article summarizes some of the findings from such investigations, including recommendations for the management of patients infected with this newly emerged pathogen. © 2010 Elsevier Inc. |
Persistent Identifier | http://hdl.handle.net/10722/182375 |
ISSN | 2023 Impact Factor: 6.1 2023 SCImago Journal Rankings: 1.360 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tang, JW | en_US |
dc.contributor.author | Shetty, N | en_US |
dc.contributor.author | Lam, TTY | en_US |
dc.contributor.author | Hon, KLE | en_US |
dc.date.accessioned | 2013-04-23T08:21:11Z | - |
dc.date.available | 2013-04-23T08:21:11Z | - |
dc.date.issued | 2010 | en_US |
dc.identifier.citation | Infectious Disease Clinics Of North America, 2010, v. 24 n. 3, p. 603-617 | en_US |
dc.identifier.issn | 0891-5520 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/182375 | - |
dc.description.abstract | Influenza viruses continue to cause yearly epidemics and occasional pandemics in humans. In recent years, the threat of a possible influenza pandemic arising from the avian influenza A(H5N1) virus has prompted the development of comprehensive pandemic preparedness programs in many countries. The recent emergence of the pandemic influenza A(H1N1) 2009 virus from the Americas in early 2009, although surprising in its geographic and zoonotic origins, has tested these preparedness programs and revealed areas in which further work is necessary. Nevertheless, the plethora of epidemiologic, diagnostic, mathematical and phylogenetic modeling, and investigative methodologies developed since the severe acute respiratory syndrome outbreak of 2003 and the subsequent sporadic human cases of avian influenza have been applied effectively and rapidly to the emergence of this novel pandemic virus. This article summarizes some of the findings from such investigations, including recommendations for the management of patients infected with this newly emerged pathogen. © 2010 Elsevier Inc. | en_US |
dc.language | eng | en_US |
dc.publisher | WB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/cind | en_US |
dc.relation.ispartof | Infectious Disease Clinics of North America | en_US |
dc.subject | Epidemiology | - |
dc.subject | H1N1 | - |
dc.subject | Influenza | - |
dc.subject | Pandemic | - |
dc.subject | Transmission | - |
dc.subject | Treatment | - |
dc.subject.mesh | Antiviral Agents - Therapeutic Use | en_US |
dc.subject.mesh | Communicable Diseases, Emerging - Drug Therapy - Epidemiology - Virology | en_US |
dc.subject.mesh | Disease Outbreaks | en_US |
dc.subject.mesh | Epithelial Cells - Virology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Influenza, Human - Drug Therapy - Epidemiology - Pathology - Virology | en_US |
dc.subject.mesh | Orthomyxoviridae - Classification - Genetics - Isolation & Purification - Pathogenicity | en_US |
dc.title | Emerging, novel, and known influenza virus infections in humans | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lam, TTY: ttylam@hku.hk | en_US |
dc.identifier.authority | Lam, TTY=rp01733 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.idc.2010.04.001 | en_US |
dc.identifier.pmid | 20674794 | - |
dc.identifier.scopus | eid_2-s2.0-77955240755 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-77955240755&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 24 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.spage | 603 | en_US |
dc.identifier.epage | 617 | en_US |
dc.identifier.isi | WOS:000281349500006 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Tang, JW=10341387300 | en_US |
dc.identifier.scopusauthorid | Shetty, N=7005372453 | en_US |
dc.identifier.scopusauthorid | Lam, TTY=36775821700 | en_US |
dc.identifier.scopusauthorid | Hon, KLE=8134452900 | en_US |
dc.identifier.issnl | 0891-5520 | - |